Banque Cantonale Vaudoise Palatin Technologies Inc Transaction History

Banque Cantonale Vaudoise

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	SELL	$0.38 - $0.78 $40,598 - $83,334	-106,839 Closed	0 $0
Q3 2020 Oct 30, 2020	SELL	$0.47 - $0.64 $20,037 - $27,285	-42,634 Reduced 28.52%	106,839 $50,000
Q2 2020 Jul 22, 2020	SELL	$0.41 - $0.73 $4,371 - $7,782	-10,661 Reduced 6.66%	149,473 $77,000
Q1 2020 May 14, 2020	SELL	$0.36 - $0.79 $9,703 - $21,293	-26,954 Reduced 14.41%	160,134 $68,000
Q4 2019 Feb 10, 2020	BUY	$0.75 - $0.89 $140,316 - $166,508	187,088 New	187,088 $146,000

2.94K

Ticker PTN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 9,290,480
Market Cap $8.83M
Description
Palatin Technologies, Inc., a biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor (MCr) agonist for the treatment of premenopausal women with hypoactive sexual desire disorder. It is also developing o...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.